I am a proud survivor of the late stage side effect chemotherapy-induced atrial fibrillation. Atrial Fibrillation or arrhythmia is frequent in patients with multiple myeloma when they receive ASCT.
Chemotherapy-induced cardiomyopathy- Cardiotoxicity of certain chemotherapy regimens is a well-documented adverse event. Chemotherapy regimens that were known to cause short, long-term and late stage damage
Will I die of cyclophosphamide (cytoxan) induced cardiomyopathy someday? Or maybe die of hemohorragic cystitis that leads to bladder cancer? Impossible to predict. I can say, however, that the chemotherapy
Our patients with early cardiac symptoms improved transiently but decompensated later and patients with no early symptoms developed cardiac symptoms more than 10 years after anthracycline therapy.